EDGAR Filing Documents for 0001144204-04-003828

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-04-003828

Filing Date

2004-03-30

Accepted

2004-03-30 12:39:20

Documents

Period of Report

2003-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		keryxform10k.htm	10-K	1551824
3		ex1031.htm	EX-10.31	38015
4		ex1032.htm	EX-10.32	67840
5		ex1033.htm	EX-10.33	7139
6		ex1034.htm	EX-10.34	117503
7		ex1035.htm	EX-10.35	14320
8		ex1036.htm	EX-10.36	22863
9		ex1037.htm	EX-10.37	137519
10		ex1038.htm	EX-10.38	150676
11		ex1039.htm	EX-10.39	20549
12		ex1040.htm	EX-10.40	71596
13		ex21_1.htm	EX-21.1	6243
14		ex23_1.htm	EX-23.1	2042
15		ex31_1.htm	EX-31.1	11485
16		ex31_2.htm	EX-31.2	11234
17		ex32_1.htm	EX-32.1	2988
18		ex32_2.htm	EX-32.2	3342
	Complete submission text file	0001144204-04-003828.txt		2239924

Mailing Address

Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965

KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)